Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 
Wednesday, November 25, 2009, 12:15PM ET - U.S. Markets close in 3 hours and 45 minutes. Dow Up 0.24% Nasdaq Up 0.22%
Amylin Pharmaceuticals, Inc. (AMLN)At 12:00PM ET: 13.66  Up 0.42 (3.17%)  
MORE ON AMLN
Quotes
Charts
News & Info
Company
Analyst Coverage
HereResearch Reports
Ownership
Financials

Research ReportsGet Research Reports for:
RECENT REPORTS
ReleasedContributorAuthorTitlePagesPrice
29-Nov-2009Freedonia Group Inc, TheThe Freedonia GroupFreedonia Focus on Weight Loss Products & Services24 $500
29-Nov-2009PriceTarget Research, Inc. N/A AMLN has a current Overall Rating of D (Negative).7 $25
25-Nov-2009New Constructs, LLC N/A AMLN: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19 $10
25-Nov-2009Pechala's ReportsLubomir PechalaAMYLIN PHARMACEUTICALS INC (AMLN=US) - REPORT FOR ACTIVE TRADERS4 $25
24-Nov-2009ValuEngine, Inc. N/A ValuEngine Industry Report for BIOTECHNOLOGY18 $49
24-Nov-2009Standard & Poor's STARS Report N/A Amylin Pharmaceuticals8 $35
23-Nov-2009PriceTarget Research, Inc. N/A Drug Intelligence Monitor: overall outlook NEUTRAL - 25 new Leaders; 25 new Laggards.65 $20
23-Nov-2009Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71 $199
23-Nov-2009Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569 $299
23-Nov-2009ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for AMLN13 $25
View All Reports for AMLN ...

Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
Get Research Reports for Another Symbol: Symbol Lookup
•Upgrades & Downgrades•Conference Calls